EMR Q4 2026 Earnings Analysis
Emerson exceeded Q4 expectations with 7% sales growth and 14% orders surge; 2027 guidance targets 5% growth with 29% EBITDA margin, though Europe and China headwinds persist.
Key Metrics
Wichtigste Erkenntnisse
- Q4 exceeded expectations with 7% sales growth, 29.1% EBITDA margin, and strong 14% orders growth across all regions
- Momentum driven by Middle East (+42%), power/LNG/semiconductor projects, and growth verticals up 21% YoY
- Europe softness and China weakness constrain 2027 guidance to 5% growth despite North America and Middle East strength
Anhören auf
Verfügbar in
Transcript
// Full episode scriptWelcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.
And I'm Jordan. Today we're diving into Emerson Electric's fourth quarter and full year fiscal 2026 results, reported November 4th.
Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.
Alright, so let's set the stage. Emerson is one of the big names in industrial automation, and this quarter they basically beat the room on almost every metric.
Yeah, let's talk numbers first. Underlying orders grew 14% in the quarter — that's a big acceleration from the 7% they posted last quarter. Sales were up 7%, adjusted EBITDA margin expanded 160 basis points to 29.1%, and adjusted EPS came in at $1.86, up 15% year over year.
And for the full year, underlying sales growth was 4%, adjusted EPS rose 10% to $6.59 — that's their sixth straight year of double-digit EPS growth, which is pretty remarkable for an industrial company this size.
Free cash flow was also strong — $3.5 billion for the year, up 9%, with an 18.6% margin. They bought back $1 billion in stock, retiring 7.2 million shares.
Now here's where it gets interesting for 2027. Guidance: underlying sales growth of about 5%, adjusted EBITDA margin of 29%, and adjusted EPS of $7.25 — that's another 10% jump. And they're planning to return $3.8 billion to shareholders next year — $2.5 billion in buybacks and $1.3 billion in dividends, including a 7% dividend per share increase.
Seventy-first consecutive year of dividend increases, by the way. That's Chuck Knight-era discipline still showing up today.
Right, and CEO Lal Karsanbhai actually opened the call referencing that legacy — the Emerson Management System built in the '70s under Knight, evolved over his own six years as CEO. There's a real cultural throughline there.
Let's get into the strategic story, because this is really a tale of two worlds. On one hand, you've got incredibly strong growth verticals — up 21% for the year, now 27% of total Emerson sales. Electrification, energy security, nearshoring — these secular trends are driving real project activity.
The Middle East numbers jumped out at me — orders up 42% in the quarter, revenue up 19%. That's happening despite an active regional conflict. Management credited strong execution and customer resilience. They won a massive petrochemical project in Qatar — the largest downstream expansion in the region in decades — plus they landed the Phase 2 expansion for LNG Canada's Kitimat facility, doubling capacity from 14 to 28 million tons per annum.
And on the LNG side broadly, they flagged 275 million tons per annum of opportunity still out there to be awarded. That's a long runway.
But then — Europe and China. The headline risk. Europe was down 1% for the year, expected to only modestly improve to low single digits in 2027. Germany, France, Italy all still soft, no inflection expected.
And China's even thornier. Forty percent of their China sales are tied to petrochemical and refining, and that sector is oversupplied — there's just no new capacity being built right now. COO Ram Krishnan was pretty blunt: until greenfield investment returns to Chinese chemical and refining, there's no turnaround story there, even though pockets like test and measurement are growing nicely — up 31% in China specifically.
That tension is exactly what came up in the Q&A. Scott Davis from Melius basically asked, "You've got orders up 14%, backlog up 11% — why is your 2027 guide only 5%?" And Lal's answer was essentially: we're building in real conservatism for Europe and China because those headwinds aren't going away.
I thought that was a refreshingly honest answer. Rather than overpromise off the order momentum, they're basically saying "we see the strength, but we're not going to bank on a region we don't trust yet."
There was also a great exchange on capital allocation. Julian Mitchell from JPMorgan asked whether the big buyback signals M&A is off the table. Lal's answer: large-scale deals aren't in the cards for this three-year cycle, but they've got plenty of firepower for bolt-on, sub-billion-dollar acquisitions. They're sticking to the capital return framework they laid out at their investor day last year.
And CFO Mike Baughman added some color on why the buyback is front-loaded — about $1.5 billion in Q1 alone. It's partly valuation opportunism, partly building in flexibility in case a bolt-on deal comes along mid-year.
One more thing worth flagging — AspenTech integration. They hit $100 million in synergies two years ahead of schedule. That's a software and systems business now posting 10.1% annual contract value growth, and segment margins there expanded nearly 500 basis points in the quarter to 32.3%.
So what does this all mean for investors going forward?
I think the story is: Emerson's automation portfolio is proving genuinely resilient. They navigated a Middle East conflict, European stagnation, and a Chinese petrochemical slump, and still delivered double-digit EPS growth. The secular tailwinds — electrification, energy security, nearshoring — are real demand drivers, especially in the U.S., which is about half of total sales and growing mid-single digits.
The risk side is clear too — if Europe or China surprise to the downside, or if the Middle East situation escalates, that 5% guide could get pressured. But management's built-in caution suggests they're not being overly rosy.
Before we wrap — everything discussed is AI-generated analysis for educational purposes. Past performance doesn't guarantee future results. Please do your own due diligence.
Looking ahead to fiscal 2027, Emerson seems to be threading the needle — leaning into growth verticals and U.S. strength while staying patient on the European and Chinese recovery. Worth watching how that order momentum translates through the backlog over the next couple quarters.
Agreed. That's it for this episode of Beta Finch.
Thanks for listening — we'll catch you next time.